Today's Rundown Weak data spur Amgen, Novartis to can pivotal Alzheimer's test Sofinnova invests in Abivax to delay cash crunch Gilead snags Lilly exec Shaw for Kite CEO position CRISPR pioneer Zhang targets brain diseases with new RNA-editing system EuroBiotech Report—BioNTech raises $325M, Osivax bags €8M, Sanofi and GSK FiercePharmaAsia—J&J-Hanmi obesity breakup; BI-Yuhan NASH tie-up; GSK sites in China, Singapore Chutes & Ladders—Former Merrimack CEO becomes new chief at Yumanity Featured Story | | | Friday, July 12, 2019 Amgen and Novartis have stopped pivotal tests of CNP520 in Alzheimer’s disease. The failure is a blow to the hypothesis that anti-amyloid drugs delay or prevent the onset of Alzheimer’s when given before patients develop symptoms. |
|
|
| This week's sponsor is Medrio. | | | [Webinar] Accelerating Site and Patient Enrollment for Phase 1 Trials
Tuesday, July 23 | 2pm ET / 11am PT
This Fierce webinar will feature clinical trial site leaders and R&D executives, who will pass along the latest strategies for boosting site and patient enrollment in phase 1 trials. They will discuss best practices for communicating with both investigators and patients. Register Now! |
Top Stories Friday, July 12, 2019 Sofinnova Partners has invested €12 million ($14 million) in Abivax, securing itself more than 10% of the company. The investment buys the biotech time to fund ABX464 to milestones while seeking a partner for the asset. Thursday, July 11, 2019 Back in May, new Gilead CEO Daniel O’Day said he’d be looking for a CEO for Gilead’s Kite unit. And he’s found his pick. Thursday, the Big Biotech said it would bring on Eli Lilly executive Christi Shaw to run the cell therapy company. Thursday, July 11, 2019 Broad Institute researchers have developed a new strategy for editing RNA they believe could someday be used to treat brain diseases like Alzheimer’s. In cells, they showed the technology can be used to target 24 disease-causing mutations. Thursday, July 11, 2019 In this week's EuroBiotech Report, BioNTech raises $325 million, Osivax pulled in €8 million and FDA accepts BLA filing for Sanofi's Darzalex rival. Friday, July 12, 2019 Janssen has scrapped an obesity drug collaboration with Hanmi after midphase trials. Yuhan signs $870 million NASH deal with Boehringer Ingelheim. GSK opens new manufacturing facilities in Singapore and sells a Chinese site to Fosun. And more. Friday, July 12, 2019 Former Merrimack CEO becomes new chief at Yumanity; Lilly Bio-Medicines chief steps aside; 23andMe's therapeutics leader leaves for board roles at up-and-coming biotechs. Those moves plus more hirings, firings and retirings throughout the industry. | This week's sponsor is ExL Events. | | | |
Resources Sponsored by: Almac Group Innovative Just in Time Manufacturing solution enables sponsors full late stage customisation of clinical trial materials Sponsored by: PwC How are employer activism strategies beginning to replace the cost-sharing of the past, and improve the health of the workforce? Sponsored by: United Cargo and SAVSU Technologies The combination of SAVSU technology with United Airlines’ global network has made it easier than ever to bring cell and gene therapies to destinations beyond major markets. Sponsored by: XiltriX North America Find out in this article how your pharmaceutical organization can leverage IoT technologies and informatics integration to innovate and improve overall operational efficiencies. Sponsored by: Patheon, by Thermo Fisher Scientific When a biologics company prepares to launch a new product, it must forecast the manufacturing capacity it will need. Learn more here. Sponsored by: Veradigm Patient demand for more information on their care is driving new e-prescribing regulations, and technology is evolving to help providers meet them. This report provides an overview of key areas where such regulation has emerged, and what it could mean for providers and healthcare IT companies. Sponsored by: Patheon, by Thermo Fisher Scientific Anticipate challenges in formulation early. Sponsored by: Titian Software This Essential Guide to Managing Laboratory Samples is a three-part piece exploring common problems experienced in the management of samples and how, for any scale of operation, significant efficiency and accuracy benefits can be gained using dedicated sample management software. Sponsored by: Veradigm Patients living with diabetes deserve better – Real-World Evidence for effecting/realizing change in the management of type 2 diabetes and cardiovascular/renal comorbidities. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. Latin America Healthcare Compliance Certificate Program September 23-26, 2019 4th FierceBiotech Drug Development Forum October 28-29, 2019 | Boston, MA Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register NOW and start Pre-Boot Camp Preparation! | 